Preliminary research out of the University of Queensland’s Institute for Molecular Bioscience indicates the cannabinoid cannabidiol is effective in killing bacteria in lab testing – including some that have become mainstream antibiotic resistant.
The research, carried out by IMB’s Centre for Superbug Solutions’ Dr Mark Blaskovich in collaboration with Australia’s Botanix Pharmaceuticals Ltd, determined cannabidiol was very effective at bowling over a wide range of gram-positive bacteria, including Staphylococcus aureus (responsible for staph infections), and Streptococcus pneumoniae; the bug responsible for pneumococcal disease.
Cannabidiol (CBD) is a non-intoxicating compound found in cannabis plants – including industrial hemp. There’s been all sorts of claims made about the therapeutic potential of CBD and while no doubt some won’t be validated, there’s mounting evidence suggesting it could be extremely useful in treating or managing various conditions.
The UQ release says there has previously been some limited evidence pointing to cannabidiol being a bacteria-killer, but CBD is yet to be thoroughly investigated for its potential use as an antibiotic.